Dyne Therapeutics Inc (DYN): A Great Stock For Handling Current Market Conditions?
Citadel Advisors LLC recently announced the acquisition of new stake in Dyne Therapeutics Inc (NASDAQ:DYN). The institutional investor has increased its shareholding in the Healthcare company by 11.54% to 3.02 million shares with purchase of 0.31 million shares. This fresh investment now brings its stake to 4.92% valued currently at $33.44 million. In addition, BlackRock […]
